ConductScience.org, home

Trial · NCT05257291

Study MIPAE - Melatonin and Essential Arterial Hypertension

NCT05257291, Phase 2, Unknown, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Study MIPAE - Melatonin and Essential Arterial Hypertension. Trials, record NCT05257291. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05257291

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Study MIPAE - Melatonin and Essential Arterial Hypertension
NCT number
NCT05257291
Status
Unknown
Phases
Phase 2
Enrollment
23 participants, actual
Lead sponsor
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Conditions
Essential Hypertension
Interventions
Melatonin
First posted
2022-02-25
Last updated
2023-02-01

Source ClinicalTrials.gov

Registered outcomes14

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryBlood pressure.Baseline.Value of ambulatory blood pressure obtained from the mean of three different misurations.
PrimaryHeart rate.Baseline.Ambulatory recorder of the heart rate of the patient.
PrimaryEndothelial parameters.Baseline.
PAT signals were obtained using the EndoPAT-2000 device, which has been vali-dated and used previously to assess peripheral arterial tone in other populations. Endothelial function is measured via a reactive hyper-emia (RH) protocol: it consists of a 5 minutes baseline mea-surement, after which a blood pressure cuff on the test arm isinflated to 60 mm Hg above baseline systolic BP or at least200 mm Hg for 5 minutes. After 5 minutes, the cuff is deflated, and the PAT tracing isrecorded for a further 5 minutes. The cal-culated ratio is called RH-PAT index or RH index (RHI).
PrimaryArterial stiffness parameters.Baseline.
The radial artery waveform was recorded using the SphygmoCor system. The tip of the tonometer was pressed gently against the radial artery at the site of maximum pulsation at the wrist. This micromanometer precisely records pressure within the artery. he augmentation pressure is defined as the height of the late systolic peak above the inflection point. Augmentation index is expressed as a percentage of PPAO. Augmentation index is a measure of the stiffness of the arterial walls, namely pulsatile load. Because there is a linear relationship between it and heart rate (HR), augmentation index was standardized to a HR of 75 bpm (AIx@75).
PrimaryEchocardiographic parameters.Baseline.
Bi-dimensional transthoracic echocardiographic examinations were performed using Vivid 9 and Vivid Q (GE Medical HealthCare, USA) with a probe of 3.5 MHz, to assess LV dimensions and systolic function, according to the guidelines. The main points were: the dimensions of atria and ventricles, stenosis and valve insufficiencies, systolic and diastolic function VS and VD, Dimensions and elastic properties of the ascending aorta (compliance, distensibility, stiffness index, elastic modulus of Peterson, PWV, M-mode strain, tissue strain).
PrimaryPlasmatic melatonin levels.Baseline.Obtained with ELISA laboratory test.
PrimaryTotal circulating antioxidant capacity in plasma.Baseline.Obtained with ELISA laboratory test.
PrimaryBlood pressure.1 year.Ambulatory blood pressure obtained from the mean of three different misurations.
PrimaryHeart rate.1 year.Ambulatory recorder of the heart rate of the patient.
PrimaryEndothelial parameters.1 year.
PAT signals were obtained using the EndoPAT-2000 device, which has been vali-dated and used previously to assess peripheral arterial tone in other populations. Endothelial function is measured via a reactive hyper-emia (RH) protocol: it consists of a 5 minutes baseline mea-surement, after which a blood pressure cuff on the test arm isinflated to 60 mm Hg above baseline systolic BP or at least200 mm Hg for 5 minutes. After 5 minutes, the cuff is deflated, and the PAT tracing isrecorded for a further 5 minutes. The cal-culated ratio is called RH-PAT index or RH index (RHI).

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers25

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
3328650BACKGROUNDPubMed
9062865BACKGROUNDPubMed
10235107BACKGROUNDPubMed
10817810BACKGROUNDPubMed
10831154BACKGROUNDPubMed
11207642BACKGROUNDPubMed
11566935BACKGROUNDPubMed
11738311BACKGROUNDPubMed
12588755BACKGROUNDPubMed
15049379BACKGROUNDPubMed

1 to 10 of 25

See all 25 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT05257291

GET https://conductscience.org/api/trials/v1/NCT05257291/papers?page=2